{
  "cik": 1815442,
  "cik_padded": "0001815442",
  "entityName": "Kymera Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-073395",
      "filed": "2026-02-26",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1449000.0,
        "cash": 357011000.0,
        "eps_diluted": -3.69,
        "free_cash_flow": -234340000.0,
        "net_income": -311351000.0,
        "operating_cash_flow": -232891000.0,
        "operating_income": -349399000.0,
        "revenue": 39211000.0,
        "stockholders_equity": 1579664000.0,
        "total_assets": 1742812000.0,
        "total_liabilities": 163148000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.10328019123054016,
        "revenue_growth_yoy": -0.16699949014276003,
        "roa_avg2y": -0.2288632914676937,
        "roa_period_end": -0.17864864368618072,
        "roe_avg2y": -0.2578174069042841,
        "roe_period_end": -0.1970995097691661
      }
    },
    {
      "accn": "0001193125-26-073395",
      "filed": "2026-02-26",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 12838000.0,
        "cash": 120256000.0,
        "eps_diluted": -2.98,
        "free_cash_flow": -207339000.0,
        "net_income": -223858000.0,
        "operating_cash_flow": -194501000.0,
        "operating_income": -261635000.0,
        "revenue": 47072000.0,
        "stockholders_equity": 835619000.0,
        "total_assets": 978035000.0,
        "total_liabilities": 142416000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.1704317398240107,
        "revenue_growth_yoy": -0.4010586319218241,
        "roa_avg2y": -0.2881437307648247,
        "roa_period_end": -0.22888546933391954,
        "roe_avg2y": -0.36382223161247856,
        "roe_period_end": -0.2678948180929347
      }
    },
    {
      "accn": "0001193125-26-073395",
      "filed": "2026-02-26",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 34480000.0,
        "cash": 109966000.0,
        "eps_diluted": -2.52,
        "free_cash_flow": -137306000.0,
        "net_income": -146962000.0,
        "operating_cash_flow": -102826000.0,
        "operating_income": -165530000.0,
        "revenue": 78592000.0,
        "stockholders_equity": 394971000.0,
        "total_assets": 575759000.0,
        "total_liabilities": 180788000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.4577247443483192,
        "revenue_growth_yoy": 0.678383803869645,
        "roa_avg2y": -0.2493220334669898,
        "roa_period_end": -0.25524915806787213,
        "roe_avg2y": -0.3320717370034865,
        "roe_period_end": -0.37208301368961266
      }
    },
    {
      "accn": "0001193125-26-073395",
      "filed": "2026-02-26",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2836000.0,
        "cash": 68395000.0,
        "eps_diluted": -2.87,
        "free_cash_flow": -155921000.0,
        "net_income": -154808000.0,
        "operating_cash_flow": -153085000.0,
        "operating_income": -161256000.0,
        "revenue": 46826000.0,
        "stockholders_equity": 490151000.0,
        "total_assets": 603134000.0,
        "total_liabilities": 112983000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.2305065173793382,
        "revenue_growth_yoy": -0.3570683216168717,
        "roa_avg2y": -0.2560843777578722,
        "roa_period_end": -0.25667264654289096,
        "roe_avg2y": -0.3259839817054104,
        "roe_period_end": -0.3158373644040306
      }
    },
    {
      "accn": "0000950170-25-028355",
      "filed": "2025-02-27",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1597000.0,
        "cash": 47976000.0,
        "eps_diluted": -2.09,
        "free_cash_flow": -130543000.0,
        "net_income": -100217000.0,
        "operating_cash_flow": -128946000.0,
        "operating_income": -100530000.0,
        "revenue": 72832000.0,
        "stockholders_equity": 459638000.0,
        "total_assets": 605905000.0,
        "total_liabilities": 146267000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.31822216613944015,
        "net_margin": -1.376002306678383,
        "operating_margin": -1.3802998681898067,
        "revenue_growth_yoy": 1.1399776693894341,
        "roa_avg2y": -0.1833662677937571,
        "roa_period_end": -0.16540051658263258,
        "roe_avg2y": -0.26957228126521465,
        "roe_period_end": -0.21803462725014033
      }
    },
    {
      "accn": "0000950170-24-018414",
      "filed": "2024-02-22",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 9096000.0,
        "cash": 31004000.0,
        "eps_diluted": -3.15,
        "free_cash_flow": 79034000.0,
        "net_income": -45593000.0,
        "operating_cash_flow": 88130000.0,
        "operating_income": -46304000.0,
        "revenue": 34034000.0,
        "stockholders_equity": 283888000.0,
        "total_assets": 487175000.0,
        "total_liabilities": 203287000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.7160816941892577,
        "net_margin": -1.339630957278016,
        "operating_margin": -1.3605218311100662,
        "revenue_growth_yoy": 10.59986366734833,
        "roa_avg2y": -0.1510009488687266,
        "roa_period_end": -0.09358649355980911,
        "roe_avg2y": -0.4352927697845161,
        "roe_period_end": -0.16060206842134928
      }
    },
    {
      "accn": "0000950170-23-003935",
      "filed": "2023-02-23",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 532000.0,
        "cash": 76015000.0,
        "free_cash_flow": 17373000.0,
        "net_income": -41246000.0,
        "operating_cash_flow": 17905000.0,
        "operating_income": -42205000.0,
        "revenue": 2934000.0,
        "stockholders_equity": -74406000.0,
        "total_assets": 116702000.0,
        "total_liabilities": 82028000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.353430104025638,
        "roe_avg2y": 0.7579059554216203
      }
    },
    {
      "accn": "0000950170-22-001860",
      "filed": "2022-02-24",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -34436000.0
      },
      "period_end": "2018-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-073395",
    "filed": "2026-02-26",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001815442.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001815442.json"
  },
  "ticker": "KYMR"
}